Αποτελέσματα Αναζήτησης
John Ouren is an Operating Partner at STG. As a part of his Operating Partner role, John was most recently Executive Chairman of Simmons Research and led the creation of the MRI-Simmons joint venture between GfK and Simmons.
12 Σεπ 2022 · John Ouren, STG Operating Partner, is appointed Executive Chairman of the Onclusive board. 12 September, New York: Global media intelligence leader, Onclusive, today announces the appointment of Rob Stone as CEO, effective immediately.
John Ouren is an Operating Partner at STG. As a part of his Operating Partner role, John was most recently Executive Chairman of Simmons Research and led the creation of the MRI-Simmons joint venture between GfK and Simmons.
John Ouren is an Operating Partner at STG. As a part of his Operating Partner role, John was most recently Executive Chairman of Simmons Research and led the creation of the MRI-Simmons joint venture between GfK and Simmons. Prior to his role at Simmons, John was the CEO of AlphaImpactRx where he grew EBITDA over 60% over his tenure.
3 Φεβ 2016 · “IMS Health is a great home for our business and our people,” said John Ouren, CEO of AlphaImpactRx. “The company has a broad global platform across many different areas in healthcare and technology, and we believe those additional capabilities will enable us to better serve our clients and grow our platform,” he said.
Follows the resignation of Manuel Moerbach from Symphony Technology Group (STG) owned Onclusive, who returns to New York to re-join his young family. John Ouren, STG Operating Partner, is appointed Executive Chairman of the Onclusive board. 20 Jul 2022.
16 Σεπ 2022 · Onclusive has also named STG operating partner John Ouren as executive chairman of its board. Ouren has worked at STG for nine years, and has prior experience working at business including MarketTools, SurveyMonkey, McKinsey & Co and AlphaImpactRx. He is also a board member at MRI-Simmons.
